Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Chunmeng Wang"'
Autor:
Mo Cheng, Qingjie Kong, Qing Tian, Weiluo Cai, Chunmeng Wang, Minjia Yuan, Wenxing Wang, Peiyuan Wang, Wangjun Yan
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background As the lethal bone tumor, osteosarcoma often frequently occurs in children and adolescents with locally destructive and high metastasis. Distinctive kinds of nanoplatform with high therapeutical effect and precise diagnosis for os
Externí odkaz:
https://doaj.org/article/b3c0b2e3f35d4567b7818d2d5558c6a6
Autor:
Zhiqiang Liu, Lingge Yang, Chun Liu, Zicheng Wang, Wendi Xu, Jueliang Lu, Chunmeng Wang, Xundi Xu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThis study seeks to enhance the accuracy and efficiency of clinical diagnosis and therapeutic decision-making in hepatocellular carcinoma (HCC), as well as to optimize the assessment of immunotherapy response.MethodsA training set comprisin
Externí odkaz:
https://doaj.org/article/baccdca43b0f4f20b37b104d2bbbefd5
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22081-22090 (2023)
Abstract Introduction Soft tissue metastasis (STM) of cancers, encompassing skeletal muscle and subcutaneous tissue metastasis, is less common due to unique homeostatic conditions. With longer life expectancy and the advent of new imaging modalities,
Externí odkaz:
https://doaj.org/article/4478b1ebf49e484b848cd49f7afbc19f
Publikováno v:
Cancer Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background Sentinel lymph node biopsy (SLNB) helps to determine accurate pathological stages and facilitates strategies for regional disease control in melanoma. However, whether the number of biopsied sentinel lymph nodes (SLNs) influences
Externí odkaz:
https://doaj.org/article/a953289ee4d14133b60c672260619fe4
Autor:
Yao Wang, Chuan Tong, Yuting Lu, Zhiqiang Wu, Yelei Guo, Yang Liu, Jianshu Wei, Chunmeng Wang, Qingming Yang, Weidong Han
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-11 (2023)
Abstract Although chimeric antigen receptor (CAR) T cells have become an important treatment option for patients with relapsed/refractory B-cell malignancies, more than 60% of patients with diffuse large B-cell lymphoma (DLBCL) treated with CAR-T cel
Externí odkaz:
https://doaj.org/article/c2db53ee38d94f4da1989b7253d882f1
Autor:
Xin Liu, Han Yue, Shiyu Jiang, Lin Kong, Yu Xu, Yong Chen, Chunmeng Wang, Yan Wang, Xiaoli Zhu, Yunyi Kong, Xiaowei Zhang, Jiang Qian, Zhiguo Luo
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16163-16172 (2023)
Abstract Purpose Metastatic ocular and orbital melanomas are extremely rare. The clinical characteristics and standard treatments for these patients are not fully established. Materials and Methods We retrospectively analyzed patients with metastatic
Externí odkaz:
https://doaj.org/article/46492fb92c4749e4b5ddbb5268380738
Autor:
Wei Sun, Yu Xu, WangJun Yan, ChunMeng Wang, Tu Hu, ZhiGuo Luo, XiaoWei Zhang, Xin Liu, Yong Chen
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 15945-15954 (2023)
Abstract Background Melanoma frequently harbors BRAF, NRAS, or KIT mutations which influence both tumor development and treatment strategies. For example, it is still controversial whether adjuvant anti‐PD‐1 monotherapy or BRAF/MEK inhibitors may
Externí odkaz:
https://doaj.org/article/67dfc44346314dda908c04c603597d27
Autor:
Jingqin Zhong, Wei Sun, Tu Hu, Chunmeng Wang, Wangjun Yan, Zhiguo Luo, Xin Liu, Yu Xu, Yong Chen
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11475-11482 (2023)
Abstract Background BRAF V600 mutation is the most common oncogenic alternation in melanoma and is visible in around 50% of cutaneous and 10%–15% of acral or mucosal subtypes. Currently, immunotherapy with anti‐PD‐1 blockade and dual‐targeted
Externí odkaz:
https://doaj.org/article/b3199656f93a4f40a0ba6b50873bce70
Autor:
Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, Yingli Sun
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-17 (2023)
Abstract Background Checkpoint blockade immunotherapy, represented by PD-1 or PD-L1 antibody treatment, has been of tremendous success in clinical practice. However, the low clinical response rate and lack of biomarkers for prediction of the immune r
Externí odkaz:
https://doaj.org/article/be4dd20a747248ef99d4a24c94a18e20
Autor:
Chunmeng Wang, Yuting Pan, Yang Liu, Bing Guo, Jinhong Shi, Guanghua Rong, Zhipeng Guo, Zhifang Li, Qingming Yang, Jing Nie, Weidong Han
Publikováno v:
MedComm, Vol 4, Iss 6, Pp n/a-n/a (2023)
Abstract Patients with relapsed/refractory classical Hodgkin lymphoma (cHL) achieve complete response (CR) after decitabine‐plus‐camrelizumab therapy, while long‐term outcome especially after treatment discontinuation remains unclear. We presen
Externí odkaz:
https://doaj.org/article/1e30c08be0a246dc86f77418e618d393